CN101181476B - External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method - Google Patents
External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method Download PDFInfo
- Publication number
- CN101181476B CN101181476B CN2007101150330A CN200710115033A CN101181476B CN 101181476 B CN101181476 B CN 101181476B CN 2007101150330 A CN2007101150330 A CN 2007101150330A CN 200710115033 A CN200710115033 A CN 200710115033A CN 101181476 B CN101181476 B CN 101181476B
- Authority
- CN
- China
- Prior art keywords
- powder
- loose
- percent
- radix arnebiae
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention belongs to the medicine technical field, in particular to an external medicine for curing a limb venous thrombus and phlebitis. The invention is characterized in that bean powder, pawpaw powder, myrrh powder, china root powder and radix arnebiae form loose powder according to the weight proportion of 80 to 85 percent, 7 to 8 percent, 2.5 to 4.5 percent, 3 to 5.5 percent and 2.5 to 3.5 percent respectively are taken to form loose powder and prepared into the invention via the following method: dry bean, dry pawpaw, dry myrrh, dry china root and dry radix arnebiae are taken to be broken into powder to make bean powder, pawpaw powder, myrrh powder, china root powder and radix arnebiae powder over 80 meshed sieve. The loose powder is made by mixing the components equably according to the above weight proportion after 10 to 20 minutes of sterilization treatment. The loose powder is filled in the inner seal of a medical plastic bag by 348g to 352g. When in use, the loose powder of 348g to 352g and 500 millilitre magnesium sulphate solution with the chroma of 5 to 20 percent are mixed into paste. The invention has the advantages of simple production art, scientific and reasonable prescription, accurate and obvious curative effect, short period of treatment, no pain and side effect to human body, low price and convenient treatment as a Chinese patent medicine, and is worthy to be promoted.
Description
Technical field
The invention belongs to field of pharmaceutical technology, particularly a kind of treatment limbs venous thrombosis, phlebitic liniment.
Background technology
Lower limb body venous thrombosis, thrombophlebitis are common clinically diseases.Gently then cause limbs pain, handicapped, heavy then threat to life.Limbs venous thrombosis, phlebitis belong to multiple stubborn disease, are difficult for curing.Treat the method for this kind disease at present both at home and abroad, mainly be that the therapy danger such as poly-, thrombolytic, anticoagulant, intervention of dispelling are higher, it is slow to take effect, easily repeatedly, the medical expense height, some patient occurs still that lower extremity swelling and distension, edema, cutaneous pigmentation, sclerosis even ulcer are prolonged does not heal after treatment.
Summary of the invention
The objective of the invention is to overcome the shortcoming of above-mentioned existence, and provide a kind of treatment short treating period, curative effect height, to human body do not have pain, have no side effect, cheap, treat Chinese patent medicine easily.
Technical scheme of the present invention is: get by weight percentage to analysis for soybean powder 80-85%, papaya powder 7-8%, do not have medicated powder 2.5-4.5%, Rhizoma Smilacis Glabrae powder 3-5.5%, Radix Arnebiae (Radix Lithospermi) powder 2.5-3.5% to form loose powder.The loose powder of per 10 grams, adding concentration is the Adlerika 10-20 milliliter composition of 5-20%.
This technical scheme preparation method be get that dried Semen Glycines, dried Fructus Chaenomelis, dried Myrrha, dry ground Poria, dried Radix Arnebiae (Radix Lithospermi) pulverize separately pulverization cross that 80 mesh sieves form analysis for soybean powder, papaya powder, do not have medicated powder, Rhizoma Smilacis Glabrae powder, Radix Arnebiae (Radix Lithospermi) powder, make loose powder by above-mentioned weight ratio mix homogeneously, made powder behind the mixing in sterilization treatment 10-20 minute.Loose powder packed into by 350 grams seal in the bag, standby.With the magnesium sulfate powder be mixed with concentration be the Adlerika of 5-20% by in 500 milliliters of bottles of packing into, standby.
Advantage of the present invention is: production technology is simple, and the medicine prescription is scientific and reasonable, determined curative effect, obvious, and cost is low, and is easy to use, have no side effect, and expense is low.
The specific embodiment
The present invention is by being analysis for soybean powder 80-85%, papaya powder 7-8% by weight percentage, not having medicated powder 2.5-4.5%, Rhizoma Smilacis Glabrae powder 3-5.5%, Radix Arnebiae (Radix Lithospermi) powder 2.5-3.5% to form loose powder.Analysis for soybean powder, papaya powder, not have medicated powder, Rhizoma Smilacis Glabrae powder, Radix Arnebiae (Radix Lithospermi) powder be by dried Semen Glycines, dried Fructus Chaenomelis, dried Myrrha, dry ground Poria, dried Radix Arnebiae (Radix Lithospermi) pulverize separately pulverization, cross 80 mesh sieves and be processed into, again by weight percentage for analysis for soybean powder 80-85%, papaya powder 7-8%, do not have behind medicated powder 2.5-4.5%, Rhizoma Smilacis Glabrae powder 3-5.5%, the Radix Arnebiae (Radix Lithospermi) powder 2.5-3.5% mixing sterilization treatment 10-20 minute and make loose powder, loose powder packed into by 350 ± 2 grams seal in the bag, standby.The magnesium sulfate powder is mixed with the Adlerika that concentration is 5-20%, in 500 milliliters of bottles of packing into, standby.
When using the loose powder of 350 ± 2 grams and 500 milliliters concentration are transferred to into pasty state as the Adlerika mixing of 5-20% and spread on affected part outsourcing one deck plastic leakage-proof thin film, after 16-18 hour medicine is taken off, medication interval 6-8 hour once more, once a day, 5-7 days was a course of treatment.
Further specify effect of the present invention with several concrete instances below.
Example 1: Wu * *, the man, 67 years old, admission number 2004004278, the retired cadre, because of the left lower extremity distending pain, uncomfortable 2 days, to be hospitalized for treatment with left lower extremity, mixed type venous thrombosis, color ultrasound examination shows that left ilium is total, the outer femoral vein of ilium, great saphenous vein thrombosis.Have a medical check-up: left lower extremity is anthorisma, and skin is sent out dim, and Pi Wen is on the low side, and joint motion is limited.Antiinflammatory, poly-, the thromboembolism treatment 29 days of dispelling, the state of an illness do not have and are clearly better, and pain increases the weight of, and can not fall asleep night.Adopted after the above medicine external application 1 day, pain relief, transference cure after 3 days, after 7 days, the color ultrasound examination vein obstruction is logical substantially again, follows up a case by regular visits to after leaving hospital, recurrence again.20% Adlerika of filling a prescription adds loose powder.
Example 2: the road * *, the man, 74 years old, the retired cadre, right leg causes thrombophlebitis because of wound, has gone over numerous large hospitals, Chinese medicine, Western medicine were all used, treat 20 surplus year, obstinate.Have a medical check-up the instep swelling of whole shank, hardening, pigmentation is livid purple color, and patient can only wear loose shoes.The patient is not in hospital, the external application for curing of being in, preceding 3 days due to illness the people to suffer from limb swelling obvious, select for use 20% magnesium sulfate to add loose powder and transfer to the pasty state external application, swelling obviously alleviates, keratinized tissue comes off, and skin color shoals, and skin is organized deliquescing, using 15% Adlerika instead adds loose powder and transfers to pasty state, external application 21 days, patient symptom disappears substantially, only leaves the scleroma of 3 * 4cm size subcutaneous tissue.
Example 3: Lee *, the woman, 36 years old, because of the breast carcinoma postoperation radiotherapy, cause the sclerosis of left skin of chest and sub-dermal soft tissue, red and swollen, burning pain, the left upper extremity limitation of activity, liniment is treated 2 courses of treatment, transference cure, local skin and soft tissue are softening.
Example 4: the king *, the man, 4 years old, because of flu, left intragluteal injection medicine caused whole buttocks redness, burning pain, and hyperpyrexia is more than 39 ℃.After treating a week, redness involves lower back, the subcutaneous tissue as hard as flint, and Chinese medicines such as external application Pulvis Radix Et Rhizoma Rhei are used antibiotics all to no effect.Below 2 days body temperature drops to 38 ℃, temperature recovery is normal after 7 days behind this medicine of external application, and symptom disappears substantially, only stays the scleroma of 2 * 2cm size in the injection site, and patient's recovery from illness is left hospital.
Claims (2)
1. treat limbs venous thrombosis, phlebitic liniment for one kind, it is characterized in that by being analysis for soybean powder 80-85%, papaya powder 7-8% by weight percentage, not having medicated powder 2.5-4.5%, Rhizoma Smilacis Glabrae powder 3-5.5%, Radix Arnebiae (Radix Lithospermi) powder 2.5-3.5% to form loose powder, the loose powder of per 10 grams, adding concentration is the Adlerika 10-20 milliliter composition of 5-20%.
2. prepare the method for the described treatment limbs of claim 1 venous thrombosis, phlebitic liniment, it is characterized in that making by the following method:
A, get dried Semen Glycines, dried Fructus Chaenomelis, dried Myrrha, dry ground Poria, dried Radix Arnebiae (Radix Lithospermi) pulverize separately pulverization, cross 80 mesh sieves and make analysis for soybean powder, papaya powder, do not have medicated powder, Rhizoma Smilacis Glabrae powder, Radix Arnebiae (Radix Lithospermi) powder, by weight percentage for analysis for soybean powder 80-85%, papaya powder 7-8%, do not have behind medicated powder 2.5-4.5%, Rhizoma Smilacis Glabrae powder 3-5.5%, the Radix Arnebiae (Radix Lithospermi) powder 2.5-3.5% mixing sterilization treatment 10-20 minute and make loose powder, loose powder packed into by 350 ± 2 grams seal in the medical plastic bag, standby;
B, with the magnesium sulfate powder be mixed with concentration be the Adlerika of 5-20% by in 500 milliliters of bottles of packing into, standby;
C, when using the loose powder of 350 ± 2 grams and 500 milliliters concentration are transferred to into pasty state as the Adlerika mixing of 5-20%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101150330A CN101181476B (en) | 2007-12-05 | 2007-12-05 | External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101150330A CN101181476B (en) | 2007-12-05 | 2007-12-05 | External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101181476A CN101181476A (en) | 2008-05-21 |
| CN101181476B true CN101181476B (en) | 2011-04-20 |
Family
ID=39446988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101150330A Expired - Fee Related CN101181476B (en) | 2007-12-05 | 2007-12-05 | External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101181476B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1672699A (en) * | 2004-03-26 | 2005-09-28 | 哈药集团制药六厂 | Medicine for treating phlebothrombosis and thrombotic superficial phlebitis of lower limb and its prepn |
| CN200951201Y (en) * | 2006-08-18 | 2007-09-26 | 王军 | Medicated plaster for treating phlebitis |
-
2007
- 2007-12-05 CN CN2007101150330A patent/CN101181476B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1672699A (en) * | 2004-03-26 | 2005-09-28 | 哈药集团制药六厂 | Medicine for treating phlebothrombosis and thrombotic superficial phlebitis of lower limb and its prepn |
| CN200951201Y (en) * | 2006-08-18 | 2007-09-26 | 王军 | Medicated plaster for treating phlebitis |
Non-Patent Citations (4)
| Title |
|---|
| 芦琳.下肢深静脉血栓形成中医治疗概况.山东中医药大学学报29 3.2005,29(3),250-252. |
| 芦琳.下肢深静脉血栓形成中医治疗概况.山东中医药大学学报29 3.2005,29(3),250-252. * |
| 颜新等.下肢深静脉血栓形成的中医药治疗进展.上海中医药杂志37 3.2003,37(3),57-61. |
| 颜新等.下肢深静脉血栓形成的中医药治疗进展.上海中医药杂志37 3.2003,37(3),57-61. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101181476A (en) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102920984A (en) | Medicine for curing rheumatoid arthritis | |
| CN101919944A (en) | Traditional Chinese medicine compound, preparation method and application thereof | |
| CN103330774A (en) | Sitz bath lotion for hemorrhoid and fistula and preparation method thereof | |
| CN102309615A (en) | Small water turtle, ginseng and pilose antler wine | |
| CN103393813B (en) | Pure Chinese herbal medicine preparation for treating burns and scalds as well as pyogenic infections and open traumas | |
| CN102670798B (en) | Traditional Chinese medicine composition for treating rheumatic arthritis, and application thereof | |
| CN101181476B (en) | External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method | |
| CN102416132B (en) | External Chinese medicine for treating psoriasis | |
| CN105250712B (en) | A kind of Chinese medicine composition for treating bedsore | |
| CN101406633A (en) | Pellet for recuperation of neck and waist | |
| CN103830360B (en) | A kind of warming the meridian and promoting blood circulation medicated wine and manufacture method thereof | |
| CN103251727A (en) | Chinese medicine powder and paste for treating burn | |
| CN102319271B (en) | Bedsore nursing powder | |
| CN105770347A (en) | Pure traditional Chinese medicinal oil for burns, scalds, wounds and ulcers and preparation method of pure traditional Chinese medicinal oil | |
| CN1970009B (en) | Chinese medicinal suppository for treating piles quickly | |
| CN101406579B (en) | Novel use of pinellia | |
| CN106334176B (en) | Chilblain ointment capable of relieving swelling, pain and itching and preparation method thereof | |
| CN101229193A (en) | External Chinese patent medicine for treating skin ulceration and organism gangrene | |
| CN110801479A (en) | Ointment for traumatic injury and sprain and preparation method thereof | |
| CN103893554A (en) | Tea oil medicinal preparation for treating skin burns and preparation method of preparation | |
| CN103028021A (en) | Traditional Chinese medicine for treating osteomyelitis and preparation method thereof | |
| CN101647938B (en) | Medicament for treating burn and scald and preparation method thereof | |
| CN101647851B (en) | Medicament for treating burn and scald and preparation method thereof | |
| CN106511676A (en) | Traditional Chinese medicine composition for treating bedsore in clinical nursing | |
| CN105362800A (en) | Medicament of treating varicosity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110420 Termination date: 20151205 |
|
| EXPY | Termination of patent right or utility model |